OrbusNeich Medical Group Holdings Ltd
HKEX:6929
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.86
8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
OrbusNeich Medical Group Holdings Ltd
PP&E Net
OrbusNeich Medical Group Holdings Ltd
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
|
PP&E Net
$18.5m
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Huakang Biomedical Holdings Co Ltd
HKEX:8622
|
PP&E Net
¥9.7m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
K
|
Kaisa Health Group Holdings Ltd
HKEX:876
|
PP&E Net
HK$25.8m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-13%
|
|
|
K
|
Kelfred Holdings Ltd
HKEX:1134
|
PP&E Net
HK$50.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Arts Optical International Holdings Ltd
HKEX:1120
|
PP&E Net
HK$353m
|
CAGR 3-Years
23%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
OrbusNeich Medical Group Holdings Ltd
Glance View
OrbusNeich Medical Group Holdings Ltd. operates as an investment holding company. The company employs 880 full-time employees The company went IPO on 2022-12-23. The firm is engaged in the design, development, manufacture, distribution and sale of interventional medical devices for the treatment of coronary heart disease and peripheral vascular diseases. The firm's main products include percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) balloons. In addition, the Company's products also include semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation and specialty catheters. The firm mainly conducts its businesses in domestic and overseas markets.
See Also
What is OrbusNeich Medical Group Holdings Ltd's PP&E Net?
PP&E Net
18.5m
USD
Based on the financial report for Dec 31, 2023, OrbusNeich Medical Group Holdings Ltd's PP&E Net amounts to 18.5m USD.
What is OrbusNeich Medical Group Holdings Ltd's PP&E Net growth rate?
PP&E Net CAGR 3Y
14%
Over the last year, the PP&E Net growth was 42%. The average annual PP&E Net growth rates for OrbusNeich Medical Group Holdings Ltd have been 14% over the past three years .
You don't have any saved screeners yet
